Nurix Therapeutics Inc <NRIX.O>: Morgan Stanley Raises Target Price to $38 From $36
NRIX•Related News
Vaxart names Kevin Finney, James Breitmeyer as board committee chairs
VXRT•
Oman presents Iran with Gulf-backed plan for voluntary fees to use Hormuz
XLE•
Firefly Neuroscience partners with Next Health on precision cognitive health platform
AIFF•
Royal Caribbean trims revenue forecast on booking hit from geopolitical tensions
RCL•
Instacart partners with Morrisons to launch Caper smart trolleys in UK store trial
CART•